Target Specific Linkers (TSLs) are a class of chemical compounds that play a critical role in pharmaceutical research and development. TSLs are designed to selectively and covalently bind to a target molecule or receptor, facilitating the delivery of therapeutic agents to specific cells or tissues while minimizing off-target effects.
TSLs typically consist of three components: a targeting moiety, a linker, and a payload. The targeting moiety is a functional group that recognizes and binds to a specific receptor or biomolecule, such as an antibody or a peptide. The linker connects the targeting moiety to the payload, which can be a therapeutic agent such as a drug or a siRNA.
TSLs are particularly useful in the field of cancer research, where they can be used to selectively deliver chemotherapy drugs to cancer cells while sparing healthy tissues. This approach can improve the efficacy and reduce the toxicity of cancer treatments, leading to better patient outcomes.
Target Specific Linkers
PEG Applications
